Myeloablative vs reduced intensity T-cell–replete haploidentical transplantation for hematologic malignancy

Abstract excerpt

Key Points Disease-free survival is higher with myeloablative regimens for patients in their third to fifth decade. Beyond the fifth decade, low-dose total body irradiation regimens offset mortality associated with transplant procedure.

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Hematopoietic Stem Cell Transplantation
• Share to Immune Cell Function and Interaction
• Share to T-cell and B-cell Immunology